Japan’s Takeda suspends new clinical trials in Russia - newspaper
TOKYO, April 10. /TASS/: Takeda Pharmaceutical has suspended new clinical trials of drugs in Russia due to the situation around Ukraine, Nikkei newspaper reports on Sunday.
The company will also halt new investments in Russia. Supplies of drugs and clinical trials will continue. Sanctions against Russia linked to its special military operation in Ukraine do not apply to the pharmaceutical business but introduced restrictions made logistics and transactions more challenging.